Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) is looking for M&A. Robert Koremans, Chief Executive Officer said, "We keep also enhancing our growth through value-accretive M&A activities, both in SPC and that is focused on Europe and in Rare Disease, which is global, and there will be focus also on the U.S. because that's where the biggest earnings and profit opportunities are in this business".
Market Closed -
Other stock markets
|
After market 03:59:58 pm | |||
49.1 EUR | +0.61% | 49.16 | +0.12% |
Apr. 24 | Global markets live: Heineken, AT&T Hasbro, Visa, Boeing... | |
Apr. 24 | CVC Said Mulling Options for Majority Stake in Recordati | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.55% | 10.76B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- REC Stock
- News Recordati
- Recordati Industria Chimica Seeks M&A